Cyclope Bio SL
Parque Tecnológico de Asturias
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- International Organization
- SAM.gov registration date
- Physical address
- Parque Tecnológico de Asturias Edificio Ceei, 33428 Parque Tecnológico de Asturias, Asturias, Spain
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $80,000 |
| FY2025 | $140,000 |
| FY2024 | $99,000 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $80,000 |
Contract awards
Similar vendors
About the company
Cyclope Bio SL, a for-profit chemical manufacturer based in Asturias, Spain, supplies specialized organic chemical compounds to the National Institute of Diabetes and Digestive and Kidney Diseases as a prime contractor under full-and-open purchase orders with no small business set-aside.
Cyclope's federal footprint is entirely concentrated with NIDDK, which accounts for all three awards totaling $319 thousand in combined potential value. The vendor supplies enantiomers of cyclopentanediamine and tetrahydrofurandiamine — chiral building blocks for peptide nucleic acid and thyclotide synthesis — in support of NIDDK's Synthetic Bioactive Molecules Section's work on diagnostic kits for nucleic-acid detection in disease research, including HIV prevention and treatment applications funded by the NIH Office of AIDS Research. Representative awards include a $99 thousand firm-fixed-price purchase order (July 2024) for enantiomers of cyclopentane diamine and tetrahydrofuran diamine with ultimate completion in December 2024; a $140 thousand sole-source purchase order (September 2025) for 100 grams each of three distinct enantiomers and research services to develop pyrrolidine analogs for thyclotide diagnostic probe development, completing September 2026; and an $80 thousand purchase order (August 2026) for 200 grams of (1S,2S)-trans-N-Boc-1,2-cyclopentanediamine as a chemical precursor for cyclopentane peptide nucleic acid and thyclotide synthesis, completing July 2027. All work is performed in Spain. Activity has been steady at one award per year since mid-2024, with one award (the August 2026 purchase order) reaching ultimate completion inside the next twenty-four months. Cyclope operates as a prime only; no sub-award activity appears in the source data.
Quick answers
Is Cyclope Bio SL registered in SAM.gov?
Yes. Cyclope Bio SL's SAM.gov registration is active through May 19, 2027.
What is Cyclope Bio SL's CAGE code?
Cyclope Bio SL's CAGE code is 9B5SB, and its Unique Entity ID (UEI) is K929DS87AWG9.
How much has Cyclope Bio SL received in federal contracts?
Federal contracts obligated $140,000 to Cyclope Bio SL in fiscal year 2025 and $319,000 in fiscal years 2023 through 2027.
How does Cyclope Bio SL rank among federal contractors?
Cyclope Bio SL ranked #37 in NAICS 32519 in FY2025.
What is Cyclope Bio SL's most recent federal award?
Cyclope Bio SL's most recent federal contract award is Niddk: supply: custom chemical: N/a (75N98026P00833), from Office of Logisitics and Acquisition Operations (NIH), on August 1, 2026.
On GovTribe
See Cyclope Bio SL's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors